CD24-positive head and neck squamous cell carcinoma (HNSCC) cell lines maintain a high capacity for self-renewal, exhibit stem-like characteristics, and possess resistance to cisplatin. This evidence concerns the gene CD24 and head and neck squamous cell carcinoma.